Edge Therapeutics, Inc. — Form D

Edge Therapeutics, Inc. of NEW PROVIDENCE, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2012-09-17. The offering totals $3.0M, of which $119K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (38)

Showing 25 of 38 people.

NameRoleLocation
Sol BarerDirectorNew Providence, NJ
Kurt ContiDirectorNew Providence, NJ
James J. LoughlinDirectorNew Providence, NJ
R. Loch MacdonaldExecutive OfficerNew Providence, NJ
Bert Loch MarchioExecutive OfficerNew Providence, NJ
Carl Loch SorannoExecutive OfficerNew Providence, NJ
R. Loch MacdonaldPromoterNew Providence, NJ
Bert Loch MarchioPromoterNew Providence, NJ
Isaac J BlechDirectorBOSTON, MA
Andrew Loch EinhornExecutive OfficerBerkeley Heights, NJ
James J LoughlinDirectorBerkeley Heights, NJ
Albert N Marchio IIExecutive OfficerBerkeley Heights, NJ
Robert J SpiegelDirectorBerkeley Heights, NJ
Kurt J ContiDirectorBerkeley Heights, NJ
Robert Loch MacdonaldDirectorBerkeley Heights, NJ
Robert Loch MacdonaldExecutive OfficerBerkeley Heights, NJ
Robert Loch MacdonaldPromoterBerkeley Heights, NJ
Herbert J FaleckExecutive OfficerBerkeley Heights, NJ
Carl J SorannoDirectorBerkeley Heights, NJ
Carl J SorannoExecutive OfficerBerkeley Heights, NJ
Carl J SorannoPromoterBerkeley Heights, NJ
Brian A LeuthnerDirectorBerkeley Heights, NJ
Brian A LeuthnerExecutive OfficerBerkeley Heights, NJ
Brian A LeuthnerPromoterBerkeley Heights, NJ
Priya Loch JambhekarExecutive OfficerNew Providence, NJ

Other filings by this issuer (6)

FiledFormOfferingSold
2015-04-09D$56.0M$56.0M
2014-11-13D$25.0M$7.9M
2013-03-25D$20.0M$6.7M
2011-06-24D$2.8M$220K
2010-11-08D/A$2.0M$635K
2009-09-16D$2.0M$500K

More